1 active not recruiting, 1 completed, 1 not yet recruiting. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Immunosuppression After Kidney Transplantation: new trials by email Literature Review of Immunosuppression After Kidney Transplantation trials Research Report on Immunosuppression After Kidney Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (TNX-1500) in Kidney Transplant Recipients TNX-1500, Kidney Transplant - Kidney Transplant, Kidney Transplant Failure and Rejection | Phase 2 | Not yet recruiting | Ayman Al Jurdi, MD | 5 | 2026-11-01 | 2026-08-19 |
| Tolerance Through Mixed Chimerism (Sip-Tego) Combined Kidney/Bone Marrow Transplant, Donation of Kidney / Bone Marrow, Conditioning Regimen (Rituxan, Siplizumab (or ATGAM), Cyclophosphamide, Tegoprubart) - Kidney Failure, Transplant Recipient (Kidney) | Early Phase 1 | Active not recruiting | Tatsuo Kawai, MD, PhD | 12 | 2025-05-31 | 2026-09-25 |
| PEL-1235_REN-0176-I (Pelicon) tacrolimus Advagraf, tacrolimus Prograf - Immunosuppression After Kidney Transplantation | Completed | Technical University of Munich | 51 | 2013-05-01 | 2018-09-13 |
Rejection, Psychology (1) · Renal Insufficiency (1)
Behavior (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Social Behavior (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Antilymphocyte Serum (1) · Cyclophosphamide (1) · Kidney Transplantation (1) · Rituximab (1) · Tacrolimus (1) · Transplantation Conditioning (1) · siplizumab (1)
Ayman Al Jurdi, MD (1) · Tatsuo Kawai, MD, PhD (1) · Technical University of Munich (1)
United States (2) · Germany (1)
Ayman Al Jurdi, MD (1) · Tatsuo Kawai, MD PhD (1)